ADHD drug study for preschoolers pulled before it began
NCT ID NCT07169162
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 38 times
Summary
This study aimed to see if a fast-dissolving ADHD medication (ADZENYS XR-ODT) could safely reduce symptoms in children aged 4 to 6 with ADHD. It was designed to compare the drug against a placebo using parent and teacher ratings. However, the study was withdrawn before any children were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Center for Psychiatry and Behavioral Medicine, Inc.
Las Vegas, Nevada, 89128, United States
Conditions
Explore the condition pages connected to this study.